BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 9732239)

  • 21. Morphological correlation of human papillomavirus infection of matched cervical smears and biopsies from patients with persistent mild cervical cytological abnormalities.
    Herrington CS; Evans MF; Gray W; McGee JO
    Hum Pathol; 1995 Sep; 26(9):951-5. PubMed ID: 7672795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between telomerase activation and HPV 16/18 oncogene expression in squamous intraepithelial lesions and squamous cell carcinomas of the uterine cervix.
    Riethdorf S; Riethdorf L; Schulz G; Ikenberg H; Jänicke F; Löning T; Park TW
    Int J Gynecol Pathol; 2001 Apr; 20(2):177-85. PubMed ID: 11293165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of cyclin-dependent kinase inhibitors p16MTS1, p21WAF1, and p27KIP1 in HPV-positive and HPV-negative cervical adenocarcinomas.
    Milde-Langosch K; Riethdorf S; Kraus-Pöppinghaus A; Riethdorf L; Löning T
    Virchows Arch; 2001 Jul; 439(1):55-61. PubMed ID: 11499840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo cyclin E expression as a marker for early cervical neoplasia.
    Quade BJ; Park JJ; Crum CP; Sun D; Dutta A
    Mod Pathol; 1998 Dec; 11(12):1238-46. PubMed ID: 9872657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value.
    Cho NH; Lim SY; Kim YT; Kim D; Kim YS; Kim JW
    Gynecol Oncol; 2003 Jul; 90(1):15-22. PubMed ID: 12821336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of human papillomavirus E6/E7 oncogene expression as cervical disease biomarker.
    Fontecha N; Basaras M; Hernáez S; Andía D; Cisterna R
    BMC Cancer; 2016 Nov; 16(1):852. PubMed ID: 27816058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer.
    Munagala R; Aqil F; Jeyabalan J; Gupta RC
    Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. E2/E6 ratio and L1 immunoreactivity as biomarkers to determine HPV16-positive high-grade squamous intraepithelial lesions (CIN2 and 3) and cervical squamous cell carcinoma.
    Choi YJ; Lee A; Kim TJ; Jin HT; Seo YB; Park JS; Lee SJ
    J Gynecol Oncol; 2018 May; 29(3):e38. PubMed ID: 29400024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV.
    Mittal KR; Lin O; Chan W; Goswami S; Demopoulos RI
    Gynecol Oncol; 1995 Sep; 58(3):289-94. PubMed ID: 7672694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variation in the E2-binding domain of HPV 16 is associated with high-grade squamous intraepithelial lesions of the cervix.
    Giannoudis A; Duin M; Snijders PJ; Herrington CS
    Br J Cancer; 2001 Apr; 84(8):1058-63. PubMed ID: 11308254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase expression in HPV infection, SILs, and cervical cancer.
    Venancio PA; Consolaro MEL; Derchain SF; Boccardo E; Villa LL; Maria-Engler SS; Campa A; Discacciati MG
    Cancer Cytopathol; 2019 Sep; 127(9):586-597. PubMed ID: 31412167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Molecular biologic study on the carcinogenesis of HPV in uterine cervical cancer and related lesions--analysis of HPV types 16, 18 E6/E7 gene mRNA].
    Nagai N
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):823-33. PubMed ID: 2172419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of folate receptors and heterogeneous nuclear ribonucleoprotein E1 in women with human papillomavirus mediated transformation of cervical tissue to cancer.
    Pillai MR; Chacko P; Kesari LA; Jayaprakash PG; Jayaram HN; Antony AC
    J Clin Pathol; 2003 Aug; 56(8):569-74. PubMed ID: 12890803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between HPV 16, 18, 31, 33, 45 DNA detection and quantitation and E6/E7 mRNA detection among a series of cervical specimens with various degrees of histological lesions.
    Baron C; Henry M; Tamalet C; Villeret J; Richet H; Carcopino X
    J Med Virol; 2015 Aug; 87(8):1389-96. PubMed ID: 25908062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus infection among Egyptian females with cervical carcinoma: relationship to spontaneous apoptosis and TNF-alpha.
    Ahmed MI; Salahy EE; Fayed ST; El-Hefnawy NG; Khalifa A
    Clin Biochem; 2001 Sep; 34(6):491-8. PubMed ID: 11676979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of human papillomavirus in warty carcinoma of the uterine cervix: comparison of immunohistochemistry, in situ hybridization and in situ polymerase chain reaction methods.
    Cho NH; Joo HJ; Ahn HJ; Jung WH; Lee KG
    Pathol Res Pract; 1998; 194(10):713-20. PubMed ID: 9820868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of cytokeratin 14 expression is related to human papillomavirus type and lesion grade in squamous intraepithelial lesions of the cervix.
    Southern SA; McDicken IW; Herrington CS
    Hum Pathol; 2001 Dec; 32(12):1351-5. PubMed ID: 11774168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P16 overexpression and human papillomavirus infection in small cell carcinoma of the uterine cervix.
    Masumoto N; Fujii T; Ishikawa M; Saito M; Iwata T; Fukuchi T; Susumu N; Mukai M; Kubushiro K; Tsukazaki K; Nozawa S
    Hum Pathol; 2003 Aug; 34(8):778-83. PubMed ID: 14506638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Quantity estimation of the E2/E6 HPV gene products ratio can be a prognostic marker for the stage of the cervical cancer carcinogenesis].
    Łukaszuk K; Liss J; Emerich J; Wójcikowski C
    Ginekol Pol; 2003 Sep; 74(9):793-8. PubMed ID: 14674126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of human papillomavirus infection on the expression of the KAI1 metastasis suppressor protein in invasive cervical cancer.
    Schindl M; Bachtiary B; Dreier B; Birner P; Latinovic L; Karner B; Breitenecker G; Oberhuber G
    Cancer Lett; 2001 Jan; 162(2):261-6. PubMed ID: 11146234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.